Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease

Abstract

ObjectiveTo assess the prevalence, timing and functional impact of psychiatric, cognitive and motor abnormalities in Huntington’s disease (HD) gene carriers, we analysed retrospective clinical data from individuals with manifest HD.MethodsClinical features of HD patients were analysed for 6316 individuals in the European REGISTRY study from 161 sites across 17 countries. Data came from clinical history and the patient-completed Clinical Characteristics Questionnaire that assessed eight symptoms: motor, cognitive, apathy, depression, perseverative/obsessive behavior, irritability, violent/aggressive behavior, and psychosis. Multiple logistic regression was used to analyse relationships between symptoms and functional outcomes.ResultsThe initial manifestation of HD is increasingly likely to be motor, and less likely to be psychiatric, as age at presentation increases, and is independent of pathogenic CAG repeat length. The Clinical Characteristics Questionnaire captures data on non-motor symptom prevalence that correlate specifically with validated clinical measures. Psychiatric and cognitive symptoms are common in HD gene carriers, with earlier onsets associated with longer CAG repeats. 42.4% of HD patients reported at least one psychiatric or cognitive symptom before motor symptoms, with depression most common. Each non-motor symptom was associated with significantly reduced total functional capacity scores.ConclusionsPsychiatric and cognitive symptoms are common and functionally debilitating in HD gene carriers. They require recognition and targeting with clinical outcome measures and treatments. However, as it is impossible to distinguish confidently between non-motor symptoms arising from HD and primary psychiatric disorders, particularly in younger pre-manifest patients, non-motor symptoms should not be used to make a clinical diagnosis of HD.

Improving Mood and Cognitive Symptoms in Huntington's Disease With Cariprazine Treatment

“…Another equally prevalent symptom in HD is depression. McAllister and colleagues ( 41 ) analyzed the prevalence, timing, and functional impact of psychiatric, cognitive, and motor abnormalities in HD in more than 6,000 individuals from the European Huntington's Disease Network 4 . They found that the most prevalent symptom after motor symptoms was depression, occurring in 64.5% of individuals with HD.…”

Juvenile‐Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review

“…Cognitive deficits are reported as initial disease signs in 30%–83% of JHD patients, before motor onset is apparent 8,21,24,25 . This wide range might be attributed to differences in description but emphasizes the notion that cognitive deficits are prominent in the initial stage of JHD.…”

FAN1 nuclease activity affects CAG expansion and age at onset of Huntington’s disease

“…For non-motor onsets, or where the clinician's onset estimate was missing, the motor component of the clinical characteristics questionnaire was instead used (ccmtrage; (McAllister et al, 2021)). The Registry population was stratified by residual age at onset and 250 (~ 4%) at each extreme of the distribution selected for analysis (exact samples depending on DNA availability) along with 7 technical exome-sequencing controls of different CAG repeat lengths and residuals of zero.…”